Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296744) titled 'Pivotal Randomized Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Supira Medical
Condition:
Coronary Artery Disease
High Risk Percutaneous Coronary Intervention
Interventional Cardiology
Mechanical Circulatory Support
Intervention:
Device: The Supira System
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: February 2026
Target Sample...